DCB at AACR 2024
DCB staff gave presentations and interacted with cancer biology researchers at the 2024 AACR Annual Meeting, which had a theme of "Inspiring Science, Fueling Progress, Revolutionizing Care.”
NCI-Selected Sessions with DCB Involvement
April 7, 2024 (2:30 PM - 3:30 PM)
Early-Onset Cancers from Etiology to Survivorship: Funding Opportunities, Resources, and Future Research Needs (NIH02)
This session had representation from across NCI Divisions, Offices, and Centers. It provided an overview of the scientific problem and discussed research gaps in etiology, prevention, and survivorship for early-onset cancers. The presentations also shared relevant NCI notices of funding opportunities, activities, and resources related to early-onset cancers.
April 7, 2024 (4:00 PM - 5:00 PM)
Cancer Health Disparities Research Collaborations Across CRCHD and DCB (NIH03)
In this session, program directors in DCB and the NCI Center to Reduce Cancer Health Disparities (CRCHD) shared collaborative NCI cancer health disparities research programs, including Basic Research in Cancer Health Disparities funding opportunities, the Integrating Health Disparities into Immuno-Oncology (HDIO) program, and Administrative Supplements to Support Cancer Disparity Collaborative Research.
Additional information about HDIO can be found in presentation slides on Integrating Health Disparities Research into Immuno-Oncology.
April 8, 2024 (10:15 AM - 11:15 AM)
NCI Funding Opportunities in Cancer Prevention and Interception (NIH04)
In this session, program directors in DCB and the NCI Division of Cancer Prevention (DCP) shared an overview of NCI funding opportunities and programs in cancer prevention and interception agent development that will address existing gaps and challenges in prevention and interception research. They shared information about the Discovery and Development of Natural Products for Cancer Interception and Prevention (DDNP-CIP), the Cancer Immunoprevention Network (CIP-Net), and PREVENT.
Additional information about a DCB-supported initiative in cancer prevention can be found in presentation slides on CIP-Net.
April 8, 2023 (12:00 PM - 1:00 PM)
Review and Funding of Foundational Cancer Biology Research at NIH & NCI (NIH05)
In this session, Dr. Dan Gallahan (DCB Director), Dr. Shannon Hughes (DCB Deputy Director), and Dr. Amy Rubenstein, (Chief of the Basic and Translational Cancer Review Branch within the NIH Center for Scientific Review) discussed current funding trends in foundational cancer biology research, new grants policies (including the NIH Data Management and Sharing Policy), and changes in peer review.
Additional information can be found in Dr. Hughes presentation slides with an Overview of NCI Grants Process and Policy Updates.
April 10, 2024 (10:15 AM - 11:15 AM)
NCI Artificial Intelligence (AI) Programs and Resources for Advancing Cancer Research (NIH12)
In this session, NCI program staff shared NCI funding opportunities, resources, and community activities that support the appropriate development and application of artificial intelligence (AI) in cancer research.
Slides from NCI Meet-the-Expert Sessions Presented by DCB Staff
April 7, 2024 (2:30 - 3:00 PM)
Cancer Immunology Funding Opportunities: Strategies for Early Career Scientists
Dr. Lillian Kuo (a DCB Program Director) presented grant strategies for early career scientists and NCI funding opportunities in cancer immunology.
April 8, 2024 (9:30 - 10:00 AM)
Investigator-Initiated Grants to Increase the Diversity of Viewpoints in Cancer Research
Drs. Shannon Hughes and Ruibai Luo (DCB Program Directors) shared information about NIH Research Enhancement Awards (R15s).
April 8, 2024 (4:30 - 5:00 PM)
Cancer Biology Research is Advancing Progress Towards the National Cancer Plan
Dr. Claire McCarthy (the DCB Communications Manager) presented how fundamental cancer biology is advancing progress towards achieving the 8 goals of the National Cancer Plan.
April 9, 2024 (10:00 – 10:30 AM)
Basic Research in Cancer Health Disparities Funding Opportunities
Dr. Anu Sharman (a DCB Program Director) shared NCI funding opportunities that support basic, mechanistic research into the biological/genetic causes of cancer health disparities.
April 9, 2024 (4:30 – 5:00 PM)
NCI AI Activities and Resources
Drs. Juli Klemm (NCI CSSI), Emily Greenspan (NCI CBIIT), Jennifer Couch (NCI DCB), and Roxanne Jensen (NCI DCCPS) presented NCI Artificial Intelligence (AI) funding opportunities and resources.
Videos of Poster Presentations Featuring DCB-Supported Researchers
DCB-supported trainees and early stage investigators share their cancer biology research (which was presented during poster sessions during AACR 2024) in short videos:
Luis Cruz presents that tumor associated macrophages produce tumor necrosis factor-like weak inducer of apoptosis (TWEAK) to support cancer stem-like cell survival and promote ovarian cancer relapse in preclinical models.
Rima Singh describes a single cell transcriptomics approach that revealed stromal and metabolic heterogeneity in liver metastatic pancreatic cancer.
Michael Ning discusses how large language models, like ChatGPT, can be used to understand drug-gene relationships in cancer.
Dr. Evanthia Roussos Torres shares that epigenetic modulation decreases myeloid cell-mediated immunosuppression to improve responses to immunotherapy in preclinical models of breast cancer.
DCB Social Media For AACR 2024
DCB social media posts about #AACR24 can be found on Twitter/X and the DCB LinkedIN Showcase Page.
Contact for DCB at AACR 2024
For additional information about DCB activities at AACR 2024, please contact Dr. Claire McCarthy.